Agentic identity management for healthcare AI agents and governance

At a glance

What this is: Imprivata’s new agentic identity management capability treats AI agents as managed identities so healthcare teams can authenticate, authorize, and audit their actions across clinical systems.

Why it matters: It matters because healthcare IAM teams now have to govern non-human actors that can touch regulated workflows, legacy systems, and patient data without weakening clinician control or compliance.

👉 Read Imprivata's announcement on agentic identity management for healthcare AI agents

Context

AI agent identity in healthcare is becoming an access governance problem, not just an automation problem. Once software can access clinical systems, scheduling, pharmacy, or lab workflows, the identity model has to decide who or what is allowed to act, under what conditions, and with what oversight. Imprivata’s announcement sits in that gap, where healthcare identity governance meets agentic AI.

The practical issue is that healthcare environments combine regulated data, safety-critical workflows, and legacy systems that are not forgiving when access is too broad or too persistent. That makes AI agent governance more demanding than ordinary workload access because the controls have to preserve clinician accountability, short-lived authorization, and auditability at the same time.

Key questions

Q: How should healthcare teams govern AI agents that access clinical systems?

A: Healthcare teams should govern AI agents as managed non-human identities with explicit roles, least-privilege permissions, and continuous auditability. The controls need to cover clinical systems, legacy platforms, and regulated workflows. If the agent can act without an owner, a scope limit, or a revocation path, the governance model is incomplete.

Q: Why do AI agents create different access risks than ordinary automation?

A: AI agents can select actions at runtime, which means their access path may change during execution. That makes static approval models and broad task-based permissions less reliable. The risk is not just automation volume. It is that the identity can move across systems in ways the original request did not fully predict.

Q: What breaks when AI agents are given broad access to healthcare workflows?

A: Broad access breaks accountability, because the agent can touch clinical, operational, or regulated data without a narrow task boundary. In healthcare, that can affect patient safety, PHI exposure, and workflow integrity. The practical failure is not only overreach. It is that the system can no longer prove why the agent was allowed to act.

Q: Who should be accountable when an AI agent makes a harmful clinical action?

A: Accountability should rest with the organisation that granted the agent access and the named business or clinical owner responsible for its operation. The agent is not an accountable party. Governance must therefore define ownership, approval boundaries, and escalation paths before the agent reaches regulated systems.

How it works in practice

Managed AI agent identities in clinical environments

Imprivata describes AI agents as managed identities rather than anonymous automation. That means each agent needs an identity record, defined roles, and explicit access permissions so the system can decide what the agent may do inside EHRs and adjacent operational tools. In practice, this is the same governance pattern used for other non-human identities, but the healthcare setting adds stricter requirements around audit trails, patient safety, and controlled delegation. The key architectural point is that the agent is not trusted because it is intelligent. It is trusted only because its identity is constrained, visible, and revocable within the enterprise control plane.

Practical implication: Practitioners should inventory AI agents as identities, not tasks, and bind each one to a named owner, role, and permission scope.

Short-lived tokens and least privilege for healthcare AI agents

The platform description centers on short-lived tokens, least-privilege access, and real-time revocation. Technically, that is a way to reduce credential persistence while keeping access usable across modern and legacy systems. Short-lived tokens lower the value of stolen credentials, but they do not remove the need to define bounded access paths and resource-level permissions. In healthcare, that matters because an agent that can reach clinical data or operational tools without tight scope control can create safety, privacy, and fraud issues even if authentication is strong.

Practical implication: Security teams should pair short-lived credentials with narrowly scoped permissions and immediate revocation paths for every agent.

Continuous monitoring, registry controls, and legacy integration

Imprivata also emphasizes a registry of authorized agents, discovery of unmanaged agents, and continuous monitoring across systems. That is a governance architecture, not just a logging feature. The registry establishes what should exist, discovery identifies what actually exists, and monitoring confirms whether agent activity stays within policy. Healthcare environments are especially difficult because modern platforms and legacy systems often have different identity semantics, which makes consistent enforcement harder. The architecture therefore has to bridge both environments without giving agents broader access simply because older systems are harder to integrate.

Practical implication: Teams should require an authoritative agent registry and continuous discovery for shadow AI before extending access to legacy clinical systems.

NHI Mgmt Group analysis

AI agents in healthcare are non-human identities first and automation second. The governance problem is not whether the workflow is useful, but whether the agent can be authenticated, scoped, and audited like any other identity that touches regulated systems. In healthcare, that distinction matters because patient safety and PHI exposure turn identity mistakes into operational risk. Practitioner conclusion: treat agent identities as part of the enterprise identity fabric, not as an add-on to workflow automation.

Least privilege for agentic AI only works when clinical intent is predictable. In human IAM, access can often be reviewed after the fact because the user’s request path is relatively stable. With agentic AI in healthcare, the agent may choose actions dynamically across systems, which makes static access definitions less reliable as a governance control. Practitioner conclusion: re-evaluate whether your current privilege model can actually describe AI behaviour in regulated workflows.

Short-lived tokens reduce credential persistence, but they do not solve the broader governance model. If the agent can still reach the wrong system, the attack surface remains, only with a shorter window. This is a control improvement, not a governance endpoint. Practitioner conclusion: measure agent access by scope and accountability, not only by token lifetime.

Shadow AI becomes a clinical governance issue when unmanaged agents can reach legacy systems. The named concept here is the runtime governance gap, where discovery, authorization, and audit controls do not cover all deployed agents. In healthcare, that gap is especially dangerous because hidden access can affect operational continuity and regulated records at the same time. Practitioner conclusion: discovery and registry control must precede broad AI deployment, not follow it.

Zero Trust in healthcare must extend to AI agents or it stops being complete. The vendor’s approach aligns with Zero Trust principles, but the discipline is broader than network segmentation. It requires continuous verification of the agent identity, the system being reached, and the task scope in every session. Practitioner conclusion: extend Zero Trust policy enforcement to non-human actors that can initiate regulated actions.

From our research:

• 96% of technology professionals identify AI agents as a growing security threat, and 66% believe this risk is immediate, according to AI Agents: The New Attack Surface report.
• Only 44% have implemented policies to govern AI agents, even though 92% agree that governing them is critical to enterprise security.
• Read OWASP Agentic AI Top 10 for the control patterns that help teams bound agent behaviour before it reaches clinical systems.

What this signals

Runtime governance gap: healthcare teams should expect agent identity sprawl to arrive faster than policy maturity. With 96% of technology professionals already calling AI agents a growing security threat, the operational question is no longer whether to govern them, but whether discovery, ownership, and audit controls can keep pace.

If AI agents can reach EHRs, scheduling platforms, and legacy clinical systems, then the reader’s programme has to extend identity governance beyond user provisioning. That means owner assignment, token lifetime, revocation logic, and access evidence must all be visible in the same control plane, not split across separate tooling silos.

The strongest near-term signal is whether unmanaged agents can be discovered before they are given production access. For teams mapping this to broader agentic AI governance, the Analysis of Claude Code Security and the OWASP Agentic AI Top 10 both reinforce the same point: runtime authority has to be constrained before the agent enters a regulated workflow.

For practitioners

• Classify AI agents as governed identities Create an identity record for every production agent, assign an accountable owner, and bind the agent to a named role with an explicit permission set across clinical and operational systems.
• Enforce short-lived tokens for all agent sessions Use short-lived tokens for AI agents so credentials do not persist beyond the task window, and pair them with real-time revocation when an agent leaves its approved workflow.
• Build an authoritative agent registry Maintain a registry of authorized agents, continuously discover unmanaged agents, and require registration before any agent can access EHRs, scheduling, pharmacy, or lab systems.
• Extend Zero Trust policy to non-human actors Apply continuous verification, least privilege, and system-level authorization checks to every agent action, especially where legacy healthcare platforms are involved.
• Tie every agent to clinician oversight Require a human owner or clinical approver for high-risk workflows such as documentation, triage, and prescription-related actions so accountability remains intact.

Key takeaways

• Healthcare AI agents are identity subjects, not just workflow tools, so governance must cover authentication, authorization, and audit together.
• The practical risk is not only access volume but access scope, because broad agent permissions can compromise patient safety and regulated data.
• Teams that cannot discover, register, and revoke agent access in real time will struggle to govern agentic AI in clinical environments.

Key terms

• Agentic Identity Management: A governance approach that treats AI agents as identities subject to authentication, authorization, monitoring, and revocation. In healthcare, it extends identity controls to software that can initiate regulated actions across clinical and operational systems, not just execute scripted automation.
• Managed Identity: A non-human identity that is formally registered, assigned a role, and governed through enterprise access controls. For AI agents, the term means the system can account for the agent’s access, ownership, and activity the same way it accounts for other production identities.
• Runtime Governance Gap: The gap between what an organisation has approved on paper and what an agent can actually do at runtime. It appears when discovery, policy, and audit controls do not fully cover dynamic agent behaviour, especially across legacy systems and regulated workflows.
• Clinician In The Loop: A control model that keeps a human clinical owner involved in higher-risk AI agent actions. It is not the same as generic human approval because the human role is tied to patient safety, accountability, and escalation boundaries inside healthcare workflows.

Deepen your knowledge

AI agent identity governance in regulated environments is a core topic in our NHI Foundation Level course, the industry's only accredited NHI security programme. If you are building controls for clinical workflows, it is worth exploring.

This post draws on content published by Imprivata: Agentic Identity Management for securing AI agents in healthcare. Read the original.